<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03135119</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00006612</org_study_id>
    <nct_id>NCT03135119</nct_id>
  </id_info>
  <brief_title>Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth</brief_title>
  <acronym>TF-CBT+AAT</acronym>
  <official_title>Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth: A Randomized Feasibility Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the incremental benefit of animal-assisted therapy (AAT) as an
      adjunct intervention when combined with Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT)
      for the treatment of maltreated youth. In addition, the development of therapeutic rapport
      and the intensity of stress experienced during treatment sessions will be examined as
      mediational mechanisms of treatment outcome. This project will help determine whether a
      larger study to test the beneficial effects of AAT for maltreated youth is feasible and
      warranted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The eventual goal of this line of research is to determine whether, and through what
      mechanisms, Animal-Assisted Therapy (AAT) is beneficial for the treatment of maltreated
      youth. The current project is a feasibility study to determine if larger clinical trials are
      warranted. The specific aims of the current study are (1) to examine whether the integration
      of AAT into standard Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) enhances treatment
      effectiveness, (2) to evaluate the tolerability and feasibility of AAT when integrated into
      TF-CBT, and (3) to evaluate hypothesized mediational processes that may explain observed
      positive effects for the integration of AAT. Maltreated youth may display myriad emotional
      and behavioral symptoms; prominent among these is posttraumatic stress (PTS). TF-CBT is a
      well-established evidence-based treatment for PTS and other symptoms subsequent to child
      maltreatment and, therefore, is a suitable intervention for this trial. Sixty (60) maltreated
      youth (ages 6-17) displaying elevated PTS will be assigned to receive TF-CBT or TF-CBT+AAT
      using a blocked randomization procedure. The TF-CBT protocol is the standard twelve 90-minute
      sessions typically used in research trials. Youth in the TF-CBT+AAT condition will receive
      the standard protocol with a certified service dog present in the room for each session and
      the youth will be allowed to interact with the dog during session. A pre-post design will be
      used to ascertain whether the addition of AAT prompts greater PTS reduction as well as
      greater improvements in other outcomes, including internalizing symptoms, externalizing
      symptoms, and emotion regulation. Outcome metrics include caregiver and youth-reported
      objective measures, and respiratory sinus arrhythmia (RSA) assessed via an electrocardiogram
      (ECG) during both a resting and stress reactivity paradigm. Feasibility metrics assessed
      include treatment satisfaction, ability to implement the TF-CBT techniques with a dog in the
      room, treatment disrupting events attributable to the dogs, and whether the dogs experience
      significant stress as a result of their participation. Stress experienced by the dog will be
      determined through RSA, salivary cortisol, and behavioral responses. Two prominent hypotheses
      regarding the mechanism of effect for AAT will be examined. First, therapeutic rapport will
      be assessed at multiple increments to determine whether the presence of the dog improved the
      quality or efficiency of development of rapport. Second, RSA will be recorded for the youth
      during treatment sessions to determine if the presence of the dog yielded a lower intensity
      of stress during the sessions. Both therapeutic rapport and level of in-session stress will
      be examined as mediating variables to determine whether either explained enhanced treatment
      outcomes. To improve the methodological rigor of the study, data will be collected by
      research assistants blinded to the youth's treatment condition and the same clinicians will
      implement both treatment conditions, thereby eliminating clinician-specific effects on
      outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2017</start_date>
  <completion_date type="Anticipated">April 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>All individuals collecting and/or handling data will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in scores on the UCLA PTSD Reaction Index for DSM-5</measure>
    <time_frame>Week 1, week 5, week 9, week 13</time_frame>
    <description>A caregiver and self-report version of the form to assess posttraumatic stress</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in scores on the Strengths and Difficulties Questionnaire</measure>
    <time_frame>Week 1, week 5, week 9, week 13</time_frame>
    <description>A caregiver report measure of youth's emotional concerns, behavioral problems, and social skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores on the Screen for Child Anxiety Related Disorders</measure>
    <time_frame>Week 1, week 5, week 9, week 13</time_frame>
    <description>A youth self-report measure of anxiety symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores on the Moods and Feelings Questionnaire</measure>
    <time_frame>Week 1, week 5, week 9, week 13</time_frame>
    <description>A youth self-report measure of depression symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores on the Emotion Regulation Checklist</measure>
    <time_frame>Week 1, week 13</time_frame>
    <description>A caregiver report measure of a youth's ability to regulate emotions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores on the Emotion Regulation Index for Children and Adolescents</measure>
    <time_frame>Week 1, week 13</time_frame>
    <description>A youth self-report measure of a youth's ability to regulate emotions</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in physiological stress response</measure>
    <time_frame>All weeks 1 - 13</time_frame>
    <description>Stress response will be measured in response to a defined stressor (Trier Social Stress Task) and during session.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in scores on the Therapeutic Alliance Scale for Children</measure>
    <time_frame>Week 2, week 4, week 13</time_frame>
    <description>A youth and caregiver-report measure that assesses perception of the quality of therapeutic rapport.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Child Abuse</condition>
  <condition>Posttraumatic Stress</condition>
  <arm_group>
    <arm_group_label>TF-CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Youth will receive standard Trauma-Focused Cognitive-Behavioral Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TF-CBT+AAT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Youth will received Trauma-Focused Cognitive-Behavioral Therapy with Animal-Assisted Therapy as an adjunct.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TF-CBT</intervention_name>
    <description>TF-CBT is typically described as including 3 phases, each focusing on a common goal and encompassing a third of treatment (4 sessions). The first phase focuses on skills-building and includes psychoeducation, parenting skills training, relaxation skills training, affect modulation skills training, and cognitive coping skills training. The second phase involves focused gradual exposure activities, including construction of a narrative account of the child's maltreatment experiences and cognitive processing of maladaptive thoughts. The third phase emphasizes the child's mastery over environmental reminders of the maltreatment and includes sharing the trauma narrative with the caregiver, in vivo exposure to physical stimuli, and enhancing future development.</description>
    <arm_group_label>TF-CBT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TF-CBT+AAT</intervention_name>
    <description>TF-CBT, as described in the other arm, with animal-assisted therapy as an adjunct intervention. During the administration of TF-CBT, a certified service dog will be in the room and the participant may elect to interact with the dog as various points throughout the sessions.</description>
    <arm_group_label>TF-CBT+AAT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A caregiver willing to participate with the youth

          -  An allegation of child maltreatment investigated by child protective services (CPS) or
             the police

          -  A raw score of â‰¥ 39 (borderline or clinical elevation) on the caregiver- report
             version of the UCLA PTSD Reaction Index for the DSM-5.

        Exclusion Criteria:

          -  Severe developmental delays and/or psychiatric problems that necessitate a higher
             level of care for the child. An allegation of child maltreatment investigated by child
             protective services (CPS) or the police

          -  Intellectual deficits for the child (IQ &lt; 80 on a cognitive screener)

          -  Caregiver inability to complete assessment measures due to psychiatric, cognitive, or
             other limitation

          -  The available caregiver is suspected or known to have perpetrated maltreatment

          -  A fear of dogs, a dog allergy, or any prior history of aggression toward animals for
             the child and/or caregiver
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Allen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brian Allen, Psy.D.</last_name>
    <phone>7175314100</phone>
    <email>ballen1@pennstatehealth.psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashley Bucher</last_name>
    <phone>7175314100</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center-TLC Research and Treatment Center</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Allen</last_name>
      <phone>717-531-4100</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Brian Allen</investigator_full_name>
    <investigator_title>Assistant Professor, Pediatrics</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The final dataset will be stripped of individual identifiers prior to release for sharing. Data subsets will only be made available to other users under data-sharing agreements that provide for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. Those wishing to access the data will need to directly contact the PI to complete the data-sharing agreement.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

